-
公开(公告)号：US20240226375A1
公开(公告)日：2024-07-11
申请号：US18380472
申请日：2023-10-16
Applicant: LifeCell Corporation
Inventor： Hui Xu , Hui Li , Ming F. Pomerleau , Darin Messina
CPC classification number: A61L27/20 , A61L27/3683 , A61L27/48 , A61M5/3129 , A61M5/32 , A61L2430/34
Abstract: Tissue product compositions and methods for treating a patient are provided. The tissue product composition may include a flowable carrier including a hyaluronic acid based material and acellular tissue matrix particles mixed within the carrier. Methods of producing the tissue product composition and an injection device filled with the tissue product composition are also provided.
-
公开(公告)号：US20240197623A1
公开(公告)日：2024-06-20
申请号：US18285570
申请日：2022-04-07
Applicant: Stealth Bio Therapeutics Inc.
Inventor： Martin P. Redmon , Ari-Pekka Forsback , Jari Mikkola , Joona Sundqvist
CPC classification number: A61K9/0024 , A61K9/06 , A61K9/1611 , A61K31/4245 , A61K38/07 , A61K41/17 , A61K47/02 , A61M5/32
Abstract: Disclosed are depot formulations comprising a biodegradable silica hydrogel composite, wherein the hydrogel composite comprises (i) a silica hydrogel; and (ii) a plurality of microparticles comprising silica and an oligopeptide or a peptidomimetic compound, or a pharmaceutically acceptable salt thereof. The depot formulations described herein provide sustained, long-term release of the active pharmaceutical compound. The depot formulations may be implanted in the eye and are useful for treating ocular diseases. The plurality of microparticles comprising silica and an oligopeptide or a peptidomimetic compound, or a pharmaceutically acceptable salt thereof can be prepared using a continuous flow process.
-
公开(公告)号：US20240173484A1
公开(公告)日：2024-05-30
申请号：US18284555
申请日：2022-03-31
Inventor： MIKHAIL ZOLOTUKHIN
CPC classification number: A61M5/3137 , A61M5/32 , A61M2205/583
Abstract: In an aspect, the present invention is directed to an injection device. The injection device includes a pneumatic piston chamber and a pneumatic piston slidably positioned within the pneumatic piston chamber; a dose chamber and an injectate piston slidably positioned within the dose chamber; and an injection completion indicator comprising a window into the piston chamber or dose chamber, wherein the injection completion indicator is aligned with a portion of the pneumatic piston chamber or the dose chamber. In another aspect, the present invention is directed to a method of administering an injection to a subject using the injection device of the invention.
-
公开(公告)号：US20240157046A1
公开(公告)日：2024-05-16
申请号：US18419298
申请日：2024-01-22
Applicant: EMED TECHNOLOGIES CORPORATION
Inventor： Paul LAMBERT
CPC classification number: A61M5/158 , A61M5/162 , A61M5/1626 , A61M5/32 , A61M5/321 , A61M5/3243 , A61M5/3257 , A61M25/0618 , A61M25/0637 , A61M2005/1581 , A61M5/3216 , A61M2005/3217 , A61M2005/325 , A61M2005/3256 , A61M5/3275
Abstract: Devices for protecting a user from a sharp tip of a medical needle includes a central body portion, a medical needle having a sharp tip, a pair of wings in attachment to the central body portion. The medical needle includes a longitudinal axis that is substantially perpendicular to at least one of a long axis of the central body portion and the delivery tube. The pair of wings are selectively positionable in a first position in which the pair of wings are spaced apart from the medical needle and a second position in which the pair of wings are proximate the medical needle. A mechanical fastener is disposed on at least one of the pair of wings, the mechanical fastener configured to selectively attach the pair of wings together in the second position with the medical needle positioned therebetween. Methods of using the device including administering medicinal fluids.
-
公开(公告)号：US20240042131A1
公开(公告)日：2024-02-08
申请号：US18381255
申请日：2023-10-18
Applicant: True Concepts Medical Technologies, LLC
Inventor： Michael Hopkins
CPC classification number: A61M5/19 , A61M5/284 , A61M5/3158 , A61B5/15003 , A61B5/150221 , A61B5/150251 , A61B5/150351 , A61B5/150992 , A61B5/153 , A61B5/154 , A61M5/31513 , A61M5/31596 , A61M5/32 , A61M2005/1787
Abstract: A syringe-based device includes a housing and an actuator mechanism including a first member and a second member. The first member includes a syringe body and a plunger, the plunger being movably disposed within the syringe body. The second member includes a second member plunger seal and a valve operably and selectively coupled to the second member plunger seal such that the valve is positioned proximal of the second member plunger seal. The device also includes a first fluid reservoir and a second fluid reservoir. The device transitions from a first configuration to a second configuration in which the first type of fluid is expelled from the first fluid reservoir, to a third configuration in which the second type of fluid is expelled from the second fluid reservoir through the valve.
-
Patent Agency Ranking
公开(公告)号：US20240017010A1
公开(公告)日：2024-01-18
申请号：US18221591
申请日：2023-07-13
Applicant: Grand Valley State University
Inventor： Robert Marshall Werner, JR. , Kelly E. Martin , Christopher P. Pung
CPC classification number: A61M5/2448 , A61M5/31513 , A61M5/32
Abstract: An injection apparatus for administering an injectant includes a mixing chamber having an impermeable membrane disposed therein, a first chamber containing a dry component, and a second chamber containing a liquid component. The dry component and the liquid component combine to form a liquid injection solution in the mixing chamber. The mixing chamber is configured to retain the liquid injection solution formed by a combination of the dry component and the liquid component. The injection apparatus is selectively configured in a plurality of states including a storage state and a mixing state.
-
公开(公告)号：US11826550B2
公开(公告)日：2023-11-28
申请号：US17673166
申请日：2022-02-16
Applicant: TRUE CONCEPTS MEDICAL TECHNOLOGIES, LLC
Inventor： Michael Hopkins
IPC: A61M5/19 , A61M5/28 , A61M5/315 , A61B5/15 , A61B5/153 , A61B5/154 , A61M5/32 , A61M5/178 , A61M5/31
CPC classification number: A61M5/19 , A61B5/153 , A61B5/15003 , A61B5/154 , A61B5/150221 , A61B5/150251 , A61B5/150351 , A61B5/150992 , A61M5/284 , A61M5/3158 , A61M5/31513 , A61M5/31596 , A61M5/32 , A61M2005/1787 , A61M2005/3128 , A61M2202/04
Abstract: A syringe-based device includes a housing and an actuator mechanism including a first member and a second member. The first member includes a syringe body and a plunger, the plunger being movably disposed within the syringe body. The second member includes a second member plunger seal and a valve operably and selectively coupled to the second member plunger seal such that the valve is positioned proximal of the second member plunger seal. The device also includes a first fluid reservoir and a second fluid reservoir. The device transitions from a first configuration to a second configuration in which the first type of fluid is expelled from the first fluid reservoir, to a third configuration in which the second type of fluid is expelled from the second fluid reservoir through the valve.
-
公开(公告)号：US11826488B2
公开(公告)日：2023-11-28
申请号：US16164975
申请日：2018-10-19
Applicant: LifeCell Corporation
Inventor： Hui Xu , Hui Li , Ming F. Pomerleau , Darin Messina
CPC classification number: A61L27/20 , A61L27/3683 , A61L27/48 , A61M5/3129 , A61M5/32 , A61L2430/34 , A61L27/48 , C08L5/08
Abstract: Tissue product compositions and methods for treating a patient are provided. The tissue product composition may include a flowable carrier including a hyaluronic acid based material and acellular tissue matrix particles mixed within the carrier. Methods of producing the tissue product composition and an injection device filled with the tissue product composition are also provided.
-
公开(公告)号：US20230355431A1
公开(公告)日：2023-11-09
申请号：US18073089
申请日：2022-12-01
Applicant: Oxular Limited
Inventor： Robert Steven Bley , Stanley R. Conston , Ronald K. Yamamoto , Tien T. Nguyen , John P. Lunsford , Dillon Daniel Martinez , Loc X. Phan
IPC: A61F9/00 , A61K9/00 , A61K9/16 , A61K31/573 , A61M5/315 , A61M25/00 , A61K47/54 , A61K9/10 , A61M5/32 , A61M5/31
CPC classification number: A61F9/0017 , A61K9/0024 , A61K9/0048 , A61K9/1647 , A61K31/573 , A61M5/315 , A61M25/0068 , A61K47/543 , A61K9/0051 , A61K9/10 , A61K9/1611 , A61K9/1635 , A61K9/1652 , A61M5/32 , A61M5/31 , A61M2205/0266 , A61M2205/587 , A61M2005/3201 , A61M5/31511 , A61M5/3243 , A61M5/31515 , A61M5/3273 , A61M2210/0612 , A61M5/178
Abstract: The present invention provides a drug composition comprising particles comprising a biodegradable or bioerodable polymer and a drug, a soluble, biodegradable or bioerodible excipient, a bulking agent and a reconstitution aid. The invention also provides a pharmaceutical formulation and a unit dosage form of the pharmaceutical formulation. The invention provides methods of treatment of a disease or condition accordingly. The invention also provides a drug composition for use in a cannulation device.
-
公开(公告)号：US20230270951A1
公开(公告)日：2023-08-31
申请号：US18006972
申请日：2021-07-21
Applicant: Koska Family Limited
Inventor： Jae-Hyok Cha , Hanjin In , Marc Andrew Koska , Jeff Price
IPC: A61M5/32
CPC classification number: A61M5/32 , A61M2005/3217
Abstract: A pre-filled medical delivery assembly assembled and configured to allow delivery of a single dose of a therapeutic agent (e.g., vaccine, drug, medicament, etc.) from a Blow-Fill-Seal (BFS) vial to a patient. The delivery assembly generally includes a modular design consisting of separately constructed components cooperatively arranged and coupled to one another.
-
-
-
-
-
-
-
-
-
Search Results
919
records
(took 0.024 seconds)
